Stocks · News reference
WELL Health Technologies Corp. was recognized as a finalist for a BC Tech award.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Welltower raised full-year normalized FFO guidance by $0.10 to $6.50 per share, driven by pricing power replacing occupancy as the primary revenue driver in senior housing. The company sourced $21 billion in investment activity year-to-date, with 85% from off-market deals. Operating margins reached post-pandemic highs at 66% flow-through, supported by rental rate growth and disciplined expense management.
Healthpeak Properties (DOC) reported Q3 2026 FFOA of $0.44 per share, beating estimates by 2.3%, with revenues up 16.3% YoY to $820.9 million. The company raised 2026 FFOA guidance to $1.76-$1.78 per share, supported by solid outpatient leasing, improving lab occupancy, and strong senior housing performance from Janus Living. However, operating expenses surged 30% YoY, and the company carries a Zacks Rank #4 (Sell) rating.
Evercore ISI Group has maintained its 'Outperform' rating on Welltower and increased its price target from $256 to $265.
Jefferies has updated its price target for Welltower Inc., increasing it from $260 to $270.
WELL Health Technologies Corp. announced it will release its fiscal third quarter 2026 financial results after market close on November 9, 2026.
Welltower Inc. saw new analyst coverage and price target adjustments on October 29, 2026, including an initiation from Freedom Capital Markets and a target revision from Cantor Fitzgerald.